Susan Raiola, President

Susan Raiola is the President of Real Endpoints. Ms. Raiola has over 10 years of experience in the pharmaceutical consulting industry with a primary emphasis on reimbursement and market access. Ms. Raiola has consulted for both large and small pharmaceutical companies and has assisted with the commercial strategy for both new and inline products. Her experience ranges across multiple therapeutic areas including immunology, gastroenterology, cardiovascular, oncology (both solid and liquid), as well as orphan diseases. She enjoys collaborating with a range of functional teams to enhance product access and reimbursement and deliver maximum value to all key stakeholders. Ms. Raiola’s clients value her market access acumen and unparalleled customer service.

Ms. Raiola has developed several novel diagnostic assessments including Hub Excellence™, which optimizes the design of patient support programs based on competitor benchmarking, key stakeholder insights, and assessments of customer unmet needs & pain points.  Ms. Raiola also developed RiQ™ (Reimbursement IQ) – a new model for measuring and enhancing reimbursement sales force effectiveness. Through both of these tools, Ms. Raiola and her team prALKe actionable insights and develop a tactical roadmap to maximize customers’ market access opportunities.

Ms. Raiola began her career as a financial analyst for Prudential, eventually managing a division responsible for individual insurance financial analysis and projections. She holds a BS in Finance, summa cum laude, from Seton Hall University. In 2019 she has recognized in PharmaVoice magazine as one of the 100 Most Inspiring Leaders in the Life Sciences.

Our Team

Jeffrey Berkowitz

CEO and Director

Mr. Berkowitz is one of the rare top executives whose career has spanned most key verticals in global healthcare -- with executive committee and....

read full biography >

Susan Raiola


Susan Raiola is the President of Real Endpoints. Ms. Raiola has over 10 years of experience in the pharmaceutical consulting...

read full biography >

Roger Longman

Founder and Chairman

Roger Longman is co-founder and chairman of Real Endpoints LLC, a leading reimbursement-focused.....

read full biography >

Jane F. Barlow, MD, MPH, MBA

EVP & Chief Clinical Officer

Jane Barlow is a clinical and strategic executive with over 25 years of healthcare leadership...

read full biography >

Ryan Walsh

Vice President, Client Services

Ryan Walsh joins Real Endpoints as Vice President for Client Services.  In this capacity, Ryan is responsible for marketing and promotional.....

read full biography >

Beth Nash, MD

Chief Medical Officer

Dr. Beth Nash is Chief Medical Officer at Real Endpoints, where her team of pharmacists and biostatisticians has developed...

read full biography >

Amy Steinkellner, PharmD

Senior Consultant

Amy Steinkellner, PharmD, has worked with the Real Endpoint team since 2012. She serves as senior clinical advisor to the research...

read full biography >

Robert Galvin, MD

Dr. Robert Galvin is the Chief Executive Officer of Equity Healthcare (EH), which oversees the management of health care for firms...

read full biography >

Michael Sherman, MD

Dr. Michael Sherman serves as Chief Medical Officer and senior vice president for Harvard Pilgrim Health Care...

read full biography >

Dennis Purcell

Dennis is the Founder, Senior Advisor, and previous Senior Managing Partner of Aisling Capital LLC.,  a leading investment firm...

read full biography >

Linda Blackerby

Linda has been serving as the President of Pharma Intelligence at Informa since May 2015, overseeing an income statement...

read full biography >

Arthur Pappas (Observer)

Art has over 30 years of experience as a pharmaceutical industry executive and venture capital investor in...

read full biography >